Role of the intestinal flora in the acetylation of sulfasalazine metabolites
- 16 November 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (21) , 3772-3774
- https://doi.org/10.1016/0006-2952(87)90034-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Will There Be a Next Generation of Sulfasalazine?Gastroenterology, 1982
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- The Effect of TopicalN-Acetyl-5-Aminosalicylic Acid in Ulcerative ColitisScandinavian Journal of Gastroenterology, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Distribution Studies of Salicylazosulfapyridine and its MetabolitesGastroenterology, 1973
- Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.Journal of Clinical Investigation, 1965